FDA Curbs Copycats as Oral Ozempic Hits 70,000 Pharmacies
Novo Nordisk gains 6% as FDA targets cheap semaglutide copies and launches first oral GLP-1 tablet in the…
FDA Curbs Copycats as Ozempic Pill Replaces Rybelsus
Novo Nordisk gains nearly 5% as FDA targets copycat weight-loss drugs and rebrands Rybelsus as the ‘Ozempic pill’…